@article{46793a40af0043a896c05e490bb93b0f,
title = "Controlling serogroup B invasive meningococcal disease: The Canadian perspective",
author = "Bettinger, {Julie A.} and Deeks, {Shelley L.} and Halperin, {Scott A.} and Raymond Tsang and Scheifele, {David W.}",
note = "Funding Information: JA Bettinger is supported by a Career Investigator Award from the Michael Smith Foundation for Health Research. JA Bettinger was also involved with ad-hoc Advisory Boards in 2010 (Novartis Vaccines, Canada) and speaker honoraria in 2010 and 2011 (Novartis Vaccines, Pfizer Inc., Baxter Inc.). SL Deeks is an Ontario provincial government employee. SA Halperin was involved with ad-hoc Advisory Board for Novartis Vaccines, Canada and speaker honoraria in the past year (Novartis Vaccines). R Tsang is a Public Health Agency of Canada employee. DW Scheifele was involved with ad-hoc Advisory Board for Novartis Vaccines, Canada. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",
year = "2013",
month = may,
doi = "10.1586/erv.13.30",
language = "English",
volume = "12",
pages = "505--517",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "5",
}
